NOVAVAX INC's ticker is NVAX and the CUSIP is 670002401. A total of 225 filers reported holding NOVAVAX INC in Q1 2023. The put-call ratio across all filers is 1.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $391 | -95.2% | 54 | -95.0% | 0.00% | – |
| Q2 2023 | $8,099 | +419.5% | 1,090 | +384.4% | 0.00% | – |
| Q1 2023 | $1,559 | -75.6% | 225 | -63.8% | 0.00% | – |
| Q4 2022 | $6,394 | +113.1% | 622 | +306.5% | 0.00% | – |
| Q3 2022 | $3,000 | -50.0% | 153 | +34.2% | 0.00% | – |
| Q2 2022 | $6,000 | +50.0% | 114 | +100.0% | 0.00% | – |
| Q1 2022 | $4,000 | -81.0% | 57 | -60.7% | 0.00% | -100.0% |
| Q4 2021 | $21,000 | -40.0% | 145 | -14.2% | 0.00% | 0.0% |
| Q3 2021 | $35,000 | +169.2% | 169 | +168.3% | 0.00% | 0.0% |
| Q2 2021 | $13,000 | +85.7% | 63 | +61.5% | 0.00% | – |
| Q1 2021 | $7,000 | +600.0% | 39 | +680.0% | 0.00% | – |
| Q4 2020 | $1,000 | -96.2% | 5 | -97.9% | 0.00% | -100.0% |
| Q3 2020 | $26,000 | +36.8% | 236 | 0.0% | 0.00% | +100.0% |
| Q2 2020 | $19,000 | +533.3% | 236 | 0.0% | 0.00% | – |
| Q1 2020 | $3,000 | – | 236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,559,918 | $543,496,000 | 8.72% |
| Foresite Capital Management I, LLC | 66,810 | $14,184,000 | 8.55% |
| Samsara BioCapital, LLC | 198,600 | $42,165,000 | 5.20% |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | 330,541 | $70,177,000 | 4.54% |
| Foresite Capital Management II, LLC | 67,373 | $14,304,000 | 3.85% |
| Rock Springs Capital Management LP | 455,000 | $96,601,000 | 1.91% |
| DELTEC ASSET MANAGEMENT LLC | 56,320 | $11,957,000 | 1.65% |
| Parametrica Management Ltd | 10,200 | $2,166,000 | 1.60% |
| SECTORAL ASSET MANAGEMENT INC | 88,450 | $18,779,000 | 1.52% |
| TSP Capital Management Group, LLC | 18,525 | $3,933,000 | 1.29% |